>
Organization
Immunomedics Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Immunomedics Inc.

... MORRIS PLAINS, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) ("Immunomedics" or the "Company"), a leading biopharmaceutical company in the ...
... Lung Cancer MORRIS PLAINS, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) ("Immunomedics" or the "Company"), a leading biopharmaceutical company in the ...
... Inhibitor Therapy MORRIS PLAINS, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) ("Immunomedics" or the "Company"), a leading biopharmaceutical company in the ...
... MORRIS PLAINS, N.J., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (NASDAQ: IMMU) ("Immunomedics" or the "Company"), a leading biopharmaceutical company in the ...
... $ 23.8 million primarily associated with Seattle Genetics' common stock holdings in Immunomedics, which are marked-to-market. For the nine months ended September 30, 2018, net ...
... of $23.8 million primarily associated with Seattle Genetics' common stock holdings in Immunomedics, which are marked-to-market. For the nine months ended September 30, 2018, net ...
... for all current investors, traders, and shareholders of Graco Inc. (NYSE:GGG), Immunomedics, Inc. (NASDAQ:IMMU), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Macquarie Infrastructure Company (NYSE:MIC), Systemax Inc. (NYSE:SYX), ...
Subscribe now for full coverage on Immunomedics Inc.
Start My Free Trial